Ignyta Inc is a precision oncology biotechnology company. Its research is targeting tumor reduction and cancer treatment through both integrated therapeutic and companion diagnostics. It aims to develop and commercialize molecularly targeted therapies.
Company profile
Website
CEO
Jonathan E. Lim
Employees
Location
Fiscal year end
Industry (SIC)
Former names
Infinity Oil & Gas Co
SEC CIK
Corporate docs
Latest filings (excl ownership)
EFFECT
Notice of effectiveness
22 Feb 18
EFFECT
Notice of effectiveness
22 Feb 18
EFFECT
Notice of effectiveness
22 Feb 18
EFFECT
Notice of effectiveness
22 Feb 18
15-12B
Securities registration termination
20 Feb 18
POS AM
Prospectus update (post-effective amendment)
12 Feb 18
POS AM
Prospectus update (post-effective amendment)
12 Feb 18
POS AM
Prospectus update (post-effective amendment)
12 Feb 18
POS AM
Prospectus update (post-effective amendment)
12 Feb 18
POSASR
Automatic shelf registration (post-effective amendment)
12 Feb 18
Latest ownership filings
SC 13G/A
Ignyta, Inc.
15 Feb 18
SC 13G/A
Ignyta, Inc.
14 Feb 18
SC 13G/A
Ignyta, Inc.
14 Feb 18
SC 13G/A
Ignyta, Inc.
14 Feb 18
SC 13G/A
Ignyta, Inc.
13 Feb 18
4
James L Freddo
12 Feb 18
4
William R McCarthy
12 Feb 18
4
Heiner Dreismann
12 Feb 18
4
Jonathan E Lim
12 Feb 18
4
James A Bristol
12 Feb 18
Institutional ownership, Q3 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|